Related by context. All words. (Click for frequent words.) 74 Meets Primary Endpoint 71 Tezampanel 70 Aliskiren 70 Panzem R 70 MAGE A3 ASCI 70 oral prodrug 70 Dalbavancin 70 Phase 2b Clinical Trial 70 Inhalation Solution 70 Onconase 69 NDA Submission 69 Muraglitazar 69 Civacir 69 Fondaparinux 69 Interferon Beta 69 CRMD# 69 histone deacetylase inhibitor 69 R#/MEM # 69 Phase 2a Trial 69 Successfully Completes Phase 69 Omalizumab 69 liposomal formulation 69 AEGR 69 lexidronam injection 69 Factor VIIa 69 Lisofylline 68 Dasatinib 68 pan HDAC inhibitor 68 Phase 2a Clinical Trial 68 TLK# 68 Immunotherapeutic 68 Panzem 68 Aflibercept 68 Completes Patient Enrollment 68 Personalized Immunotherapy 68 Maribavir 68 selective androgen receptor modulator 68 DNA intercalator 68 Mg Usa 68 reslizumab 68 AEG# 68 Phase III Clinical Trial 68 mertansine 68 Anticancer Compound 68 RhuDex 68 HDAC Inhibitor 68 Moxifloxacin 68 Drug Candidate 68 Febuxostat 68 Initiate Phase 68 Trandolapril 68 JAK Inhibitor 68 Calcitonin 68 Randomized Phase 68 GW# [003] 68 investigational humanized monoclonal antibody 68 YONDELIS 68 Darapladib 67 Phase IIb Trial 67 Phase 2b Trial 67 Combination REOLYSIN R 67 Submits NDA 67 riociguat 67 PRTX 67 Naproxcinod 67 Archexin 67 Novel Oral 67 sorafenib tablets 67 targeted radiotherapeutic 67 Pivotal Phase III 67 Silodosin 67 Medoxomil 67 Initiates Enrollment 67 Romiplostim 67 LibiGel ® 67 Aurora Kinase 67 Vandetanib 67 oral proteasome inhibitor 67 MGd 67 PRT# 67 Initiate Clinical Trial 67 Hsp# Inhibitor 67 highly selective inhibitor 67 Antiangiogenic 67 SinuNase ™ 67 lucinactant 67 Degarelix 67 Prolongs Survival 67 cathepsin K inhibitor 67 Randomized Double blind 67 Vidofludimus 67 Nexavar ® 67 AAG geldanamycin analog 67 intranasal formulation 67 Pertuzumab 67 Talabostat 67 Vidaza azacitidine 67 Aviptadil 67 JAK inhibitor 67 Anavex #-# 67 Recombinant Human 67 Bortezomib 67 CYP#A# CYP#D# 67 Cethrin R 67 histone deacetylase HDAC inhibitor 67 Pemetrexed 67 Romidepsin 67 Mg Uk 67 Sevelamer 67 non nucleoside inhibitor 67 KRN# 67 TRO# 67 Xyfid TM 67 Milestone Payment 67 Mipomersen 67 Panitumumab 67 ATL/TV# 66 Ozarelix 66 novel histone deacetylase 66 GSK# [002] 66 CTAP# Capsules 66 Tasimelteon 66 PS# [001] 66 xanthine oxidase inhibitor 66 PNP inhibitor 66 Myocet 66 telaprevir VX 66 Pivotal Phase 66 IL# PE#QQR 66 HQK 66 thetreatment 66 Thrombin 66 inhibitor rofecoxib 66 Initiates Clinical 66 Firazyr 66 IMiDs ® 66 Phase Ib Clinical Trial 66 elotuzumab 66 Xanafide 66 metaglidasen 66 virus HCV protease inhibitor 66 non peptidic protease 66 Thelin TM 66 Panzem ® 66 TBC# 66 Glufosfamide 66 Hycamtin ® 66 etanercept Enbrel 66 renin inhibitor 66 Biomarker Study 66 Angiotensin Converting Enzyme 66 PDE4 inhibitor 66 beta 1a 66 Cytochrome P# 66 Safinamide 66 ARRY # 66 cysteamine bitartrate 66 forodesine 66 Expanded Indication 66 Icatibant 66 Investigational Treatment 66 Golimumab 66 Pazopanib 66 IV Busulfex 66 ORENCIA R 66 NeuroSTAT ® 66 orally administered inhibitor 66 pan histone deacetylase 66 mesylate 66 RhuDex ® 66 Benazepril 66 Sitagliptin 66 Phase #b/#a clinical 66 PEG SN# 66 Investigational Compound 66 Diabetic Neuropathy 66 Androxal TM 66 galiximab 66 Cloretazine 66 CIMZIA TM 66 Boceprevir 66 Omacetaxine 66 Lp PLA 2 66 Teriparatide 66 LE SN# 66 PEGylated interferon 66 Vimpat R 66 THR beta agonist 66 MEK inhibitor 66 Elagolix 66 Copegus ribavirin 66 lumiliximab 66 evaluating tivozanib 66 CCX# 66 Initiates Clinical Trial 66 Peginterferon alfa 2b 66 thalidomide Thalomid 66 SIMCOR 66 IRX 2 66 Dapagliflozin 66 Glypromate 66 Pulmonary Arterial Hypertension 66 Systemic Delivery 66 Fabry Disease 66 Mycophenolate Mofetil 66 Panzem R NCD 66 eprotirome 66 Carvedilol 66 SinuNase TM 66 Cyclooxygenase 2 66 Ocrelizumab 66 Bicifadine 66 Celebrex celecoxib 66 FOLOTYN ® 66 Lysteda 66 Camptosar ® 66 Ranolazine 66 OMP #R# 65 Deforolimus 65 sitaxsentan 65 Oral Fingolimod 65 selective inhibition 65 samarium Sm 65 Azacitidine 65 acyclovir Lauriad R 65 SPRYCEL ® 65 orally dosed 65 rasagiline tablets 65 Therapeutic Vaccine 65 Fulvestrant 65 RECOTHROM R 65 Bosentan 65 Liposomal 65 octreotide acetate 65 INT# [002] 65 Epirubicin 65 atacicept 65 2 methoxyestradiol 65 First Patient Dosed 65 ALN HPN 65 small molecule tyrosine 65 PDX pralatrexate 65 Cannabinor 65 Tigecycline 65 Receives Orphan Drug Designation 65 midstage clinical 65 Initiates Phase II 65 polymerase inhibitor 65 TOCOSOL Paclitaxel 65 Noxafil 65 selective kinase inhibitor 65 MEK Inhibitor 65 Files IND 65 azilsartan medoxomil 65 PSMA ADC 65 Tyrima 65 CINOD 65 selective estrogen receptor modulator 65 adalimumab Humira 65 Saforis 65 R#/MEM 65 TPI ASM8 65 Achieves Primary Endpoint 65 Antitumor Activity 65 SUTENT ® 65 lomitapide 65 selective A2A adenosine receptor 65 Daclizumab 65 sargramostim 65 sodium glucose cotransporter 65 Technosphere ® 65 tubulin inhibitor 65 Cethromycin 65 First Patient Enrolled 65 Granulocyte Colony Stimulating Factor 65 G#DT 65 novel VDA molecule 65 5 Fluorouracil 65 urocortin 2 65 ADP receptor antagonist 65 HuMax EGFr 65 Sapacitabine 65 Kamada AAT 65 alvespimycin 65 trastuzumab Herceptin 65 systemic immunosuppressive drugs 65 TAFA# 65 Ticagrelor 65 Anti Tumor 65 Dacogen decitabine 65 KSP inhibitor 65 immunotoxins 65 Intravitreal 65 Novel Antibiotic 65 XP# XP# 65 MORAb 65 EVIZON TM 65 Ixempra 65 EZN 65 therapeutic monoclonal antibody 65 DAVANAT 65 Ramoplanin 65 candesartan cilexetil 65 Interferon Gamma 65 Darinaparsin 65 Demonstrates Significant 65 RiVax 65 Rheumatoid Arthritis Drug 65 Pradefovir 65 Epidermal Growth Factor Receptor 65 Initiates Phase III 65 REP# 65 Exforge HCT 65 Phase III Pivotal 65 Protease Inhibitor 65 histone deacetylase HDAC 65 proteasome inhibitor 65 INCB# [001] 65 non nucleoside 65 Panzem NCD 65 Faropenem 65 HuMax HepC TM 65 Clinical Trial Results 65 Pirfenidone 65 Vidaza ® 65 RezularTM 65 ZOLINZA 65 efaproxiral 65 Aganocide 65 CYT# potent vascular disrupting 65 Kinase Inhibitor 65 Severe Sepsis 65 PHX# 65 PDUFA Date 65 Interferon beta 1a 65 PHASE III 65 Liprotamase 65 Tipranavir 65 HuLuc# 65 UPLYSO 65 selective adenosine 65 insulin sensitizing 65 nucleotide analog 65 Ampakine 65 AMD# [003] 65 Abiraterone 65 Valopicitabine 65 HIF PH inhibitors 65 Tykerb lapatinib 65 Cloretazine ® 64 Anidulafungin 64 Pafuramidine 64 Vidaza R 64 Epratuzumab 64 protein tyrosine phosphatase 1B 64 histamine dihydrochloride 64 Bayer Onyx 64 molecular imaging radiopharmaceutical 64 CBLC# 64 TLR9 agonist 64 PANVAC VF 64 HDL Mimetic Peptide 64 Levetiracetam 64 Genz # 64 Tarceva TM 64 Zorbtive TM 64 acetonide FA 64 adult mesenchymal stem 64 selective modulator 64 Pooled Analysis 64 Ad5FGF 4 64 Patient Enrollment 64 polysaccharide polymer 64 rhMBL 64 rNAPc2 64 Phenoptin 64 LymphoStat B belimumab 64 Phase 1b trial 64 vapreotide acetate 64 INTEGRILIN R 64 PSN# [002] 64 Presents Preclinical 64 Parathyroid Hormone 64 FDA Approvals 64 ZEVALIN ® 64 Optimer Pharma 64 NV1FGF 64 OvaRex R 64 Filgrastim 64 treat hyperphosphatemia 64 factor VIIa 64 candidate deforolimus 64 AZILECT R 64 Sudhir Agrawal D.Phil 64 LEP ETU 64 FDA APPROVES 64 Cleviprex TM clevidipine 64 Anticancer Drug 64 BAL# [002] 64 IAP inhibitors 64 dihydrochloride 64 Elotuzumab 64 Pivotal Study 64 Azedra 64 Perifosine 64 Vicriviroc 64 Indomethacin 64 PROSTASCINT R 64 Gamunex C 64 Regeneron Pharma 64 TNF Tumor Necrosis Factor 64 Lisofylline LSF 64 5 HT3 antagonist 64 vorinostat 64 Exelixis XL# 64 Ramelteon 64 Phase IIb Clinical Trial 64 SPL# Gel vaginal microbicide 64 IND Application 64 Avanafil 64 Treated Patients 64 Triapine R 64 hyaluronidase enzyme 64 generation purine nucleoside 64 Nipent R 64 phase IIa clinical 64 antiangiogenic agent 64 non nucleoside HCV 64 hyperphenylalaninemia HPA due 64 Metastatic Melanoma 64 Clinical Trial Data 64 Pegloticase 64 Anticancer Agent 64 Microplasmin 64 bortezomib Velcade 64 ularitide 64 BrachySil TM 64 sorafenib Nexavar 64 DGAT 64 IAP inhibitor 64 adenosine A2A 64 JAK2 Inhibitor 64 Amplimexon 64 Ganciclovir 64 TransVax TM 64 targeted antifolate 64 Galantamine 64 EndoTAG TM -1 64 Replacement Therapy 64 receptor tyrosine kinase inhibitor 64 HSP# inhibitor 64 J Am Coll 64 Temsirolimus 64 Intravenous CP 64 sulindac 64 Phase III Clinical Trials 64 uricase 64 brivaracetam 64 Valsartan 64 Inhalation Aerosol 64 Irinotecan 64 glatiramer 64 plasma kallikrein inhibitor 64 Tanespimycin 64 pertuzumab 64 Initiated Phase 64 Exelixis compounds 64 Gout Drug 64 OHR/AVR# 64 IMiDs R 64 cannabinor 64 humanized monoclonal 64 XL# XL# 64 teriflunomide 64 Generic Version 64 Exherin TM 64 Ecallantide 64 panitumumab Vectibix 64 Pimavanserin 64 Epanova 64 MOVIPREP R 64 Preclinical Data 64 mGluR2 NAM 64 eltrombopag 64 albiglutide 64 Bezielle 64 BGC# 64 Cetrorelix 64 Rigel R# 64 MOZOBIL 64 esomeprazole Nexium 64 ganetespib 64 Preclinical Study 64 oral picoplatin 64 lenalidomide Revlimid R 64 levocetirizine 64 neratinib 64 Cytotoxic 64 SNT MC# 64 Belerofon 64 MEVACOR 64 Aganocide ® 64 Montelukast 64 HCl Tablets 64 SGLT 64 Trodusquemine MSI 64 PSN# [001] 64 HCV polymerase 64 Cholesterol Lowering Drug 64 Leukine ® 64 NEUGENE 64 inhibitor RG# 64 Maleate 64 Cancidas 64 HCV protease inhibitor 64 Alvine Pharmaceuticals 64 Etravirine 64 Cytarabine 64 mapatumumab 64 MTP inhibitor 64 glucagon receptor 64 Bucindolol 64 Traficet EN 64 2 inhibitor CYT# 64 tipifarnib 64 EP #R 64 Genasense ® oblimersen 64 immunotherapeutic vaccine 64 AstraZeneca Symbicort 64 Eluting Stent 64 Lubiprostone 64 anti amnesic 64 successfully commercialize Iluvien 64 AeroLEF TM 64 Dabigatran etexilate 64 Bevirimat 64 Intranasal 64 Xeloda ® 64 RGB # 64 Gefitinib 64 INTEGRILIN ® 64 Interferon alpha 64 Vfend 64 Lenalidomide 64 PEGylated Fab fragment 64 COX Inhibiting Nitric Oxide 64 Phase IIA 64 Pioglitazone 63 Ceflatonin R 63 CD# CEA 63 SILENOR 63 Keryx Biopharma 63 DNA demethylating agent 63 Vion Pharmaceuticals 63 BIM #A# 63 BUPHENYL R 63 brivanib 63 LT NS# 63 Interferon beta 63 Monoclonal Antibody 63 Vaccine Adjuvant 63 oral renin inhibitor 63 Granted Orphan Drug 63 busulfan 63 Bevacizumab 63 CCR9 antagonist 63 Velcade bortezomib 63 REG1 Anticoagulation System 63 alefacept 63 XL# anticancer compounds 63 iobenguane 63 Files Investigational 63 Iloperidone 63 Vascugel 63 rxRNA 63 methylnaltrexone bromide 63 candidate epratuzumab 63 GIPET 63 Bicalutamide 63 alpha#beta# 63 Azathioprine 63 Carfilzomib 63 Posaconazole 63 colesevelam HCl 63 IMA# 63 Teysuno 63 mTOR kinase 63 estrogen receptor antagonist 63 Elocalcitol 63 Qutenza TM 63 5 HT4 63 oral rivaroxaban 63 Eltrombopag 63 aripiprazole Abilify 63 mitogen activated ERK kinase 63 Soriatane 63 recombinant FVIII 63 Telbivudine 63 Ambrisentan 63 Glatiramer acetate 63 interferon gamma 1b 63 Losartan 63 CRx 63 dasatinib Sprycel 63 PF # [002] 63 Squalamine 63 XYOTAX TM 63 Vascular Disrupting Agent 63 liposome encapsulated 63 Nektar PEGylation technology 63 oral salmon calcitonin 63 Aptivus ® 63 FS Antihemophilic Factor Recombinant 63 Trofex 63 immunotoxin 63 Treat Parkinson Disease 63 ISIS # 63 TREDAPTIVE 63 Sumatriptan Succinate 63 fosbretabulin 63 GALNS 63 Angiocept 63 LAB CGRP 63 RLY# 63 Submits Response 63 davunetide intranasal AL 63 Candesartan 63 PLK1 SNALP 63 Demonstrated Significant 63 epoetin alpha 63 Kuvan R 63 multi kinase inhibitor 63 Arno Therapeutics 63 MYDICAR 63 GRN# 63 Locteron ® 63 lapatinib Tykerb 63 Hormone Refractory Prostate Cancer 63 Dual Opioid TM 63 HuMax CD4 63 Acute Ischemic Stroke 63 ACOMPLIA R 63 Adenoscan R 63 6R BH4 63 GLYX 63 apricitabine ATC 63 selective orally bioavailable 63 Xcytrin R 63 Ixabepilone 63 Lupus Drug 63 cobiprostone 63 vidofludimus 63 selective antagonist 63 Adentri 63 Dyloject TM 63 inhibitor PPI 63 Atrasentan 63 LY# [003] 63 Bafetinib 63 Nexavar sorafenib 63 CIMZIA TM certolizumab pegol 63 selective androgen receptor modulators 63 ALN PCS 63 Presents Preclinical Data 63 prucalopride 63 TRISENOX ® 63 vascular disrupting agents 63 Topline Results 63 Initiate Phase III 63 Chemoprevention 63 trastuzumab DM1 T DM1 63 Pyridorin 63 ARIXTRA R 63 chronic idiopathic thrombocytopenic purpura 63 incyclinide 63 cortisol synthesis 63 novel topoisomerase 63 mGluR2 positive 63 Proellex TM 63 Evoltra ® 63 Neulasta R 63 Formoterol 63 investigational protease inhibitor 63 mTOR mammalian target 63 Syncria R 63 casopitant 63 midstage trials 63 Isis Pharma 63 MYDICAR ® 63 5 HT6 receptor 63 Phase 1b Clinical Trial 63 Removab 63 HuMax TAC 63 Advanced Melanoma 63 Rotavirus Vaccine 63 Generic Versions 63 developing Zerenex ferric 63 VA# [002] 63 BCR ABL inhibitor 63 Elvitegravir 63 epoetin zeta 63 oral FTY# 63 Olmesartan 63 Activity Assay 63 torezolid phosphate 63 CORT # 63 Preclinical studies suggest 63 refractory chronic lymphocytic 63 BZL# 63 oral ridaforolimus 63 Eculizumab 63 DU #b 63 JAK2 inhibitor 63 Phase Ib II 63 DUROS 63 deforolimus 63 Late Breaker 63 Pramlintide 63 Glatiramer Acetate 63 generation Hsp# inhibitor 63 ALN TTR 63 acadesine 63 Psoriasis Drug 63 Fast Track Status 63 ISTODAX 63 Saquinavir 63 Orphan Status 63 gefitinib Iressa 63 Adjuvant Treatment 63 relapsed MM 63 rThrombin 63 Interferon alfa 63 corticosteroid dexamethasone 63 Study Showed 63 Phase III ADT 63 HoFH 63 Elesclomol 63 Proteo 63 sodium thiosulfate STS 63 defensin mimetic antibiotic 63 PARP inhibitor 63 docetaxel Taxotere ® 63 ApoB SNALP 63 Tekturna HCT 63 Zoraxel 63 Bazedoxifene 63 MKC# 63 Hycamtin 63 MyVax 63 Initiates Clinical Trials 63 bevacizumab Avastin ® 63 Phase 2a clinical trials 63 prescribed proton pump 63 ALV# 63 Metformin HCl 63 Erlotinib 63 Certican 63 FOLFOX6 chemotherapy regimen 63 inhaled AAT 63 Solulin 63 ALVESCO R 63 tanespimycin 63 sulodexide 63 Combunox 63 Quinamed 63 varespladib 63 Rebif ® 63 MGCD# [001] 63 Eribulin 63 Nanobody ® 63 Kahalalide F 63 Treanda bendamustine 63 APTIVUS 63 Novel Mechanism 63 Denufosol 63 epothilones 63 Presents Positive 63 OMNARIS HFA 63 ALGRX 63 epigenetic therapies 63 Septin 9 63 Elafin 63 CINTREDEKIN BESUDOTOX 63 novel prodrug 63 Milestone Payments 63 Zarnestra 63 Telatinib 63 mGluR5 NAM 63 HCV replicon 63 selective immunoproteasome inhibitor 63 CIMZIA ™ 63 INSPIRE Trial Phase III 63 Epothilones 63 Ustekinumab 63 Angiox ® 63 Virulizin ® 63 Phase Ib clinical trials 63 Vaprisol 63 Begins Dosing 63 CYT# QbG# 63 Initiates Phase 2b 63 pain palliation 63 Actimmune ® 63 metastatic malignant 63 Mirapexin 62 FACTIVE R gemifloxacin 62 cMET 62 Hepatotoxicity 62 preclinical efficacy 62 TORISEL TM 62 PTK# 62 Arcalyst 62 Second Pivotal Phase 62 DPX Survivac 62 depsipeptide 62 Commence Phase 62 cytoprotective 62 Aegerion Pharmaceuticals 62 Antithrombin 62 ENMD # 62 MGN# 62 Schizophrenia Drug 62 Topiramate 62 ocular formulation 62 Mitoxantrone 62 Tacrolimus 62 topically applied SEPA 62 favorable pharmacokinetic profile 62 MET VEGFR2 62 catheter occlusion 62 vinorelbine tartrate 62 Perforomist ™ Inhalation Solution 62 adecatumumab MT# 62 Celecoxib 62 Targretin capsules 62 Davanat 62 Darusentan 62 antibody MT# 62 MEK inhibitors 62 compound INCB# 62 antisense inhibitor 62 anidulafungin 62 BioVant 62 Zemiva TM 62 immune modulatory 62 Enzastaurin 62 SARMs 62 Solorel TM 62 Belimumab 62 pomalidomide 62 HCl Injection 62 STRIDE PD 62 Interferon beta 1b 62 orally bioavailable 62 BNC# 62 HMG CoA reductase inhibitors 62 reduce serum phosphate 62 glucokinase activator 62 antifibrotic 62 AZILECT ® 62 BrachySil 62 Tumour Vascular Disrupting Agent 62 Cyclooxygenase Inhibiting Nitric Oxide 62 CCR1 62 Prodrug 62 Zerenex 62 lanthanum carbonate 62 ThermoDox ® clinical 62 Thiovir 62 LEVADEX ™ 62 Vertex hepatitis C 62 Insegia 62 Sustiva efavirenz 62 VIVITROL ® 62 Sangamo BioSciences Announces 62 Tiotropium 62 Nesiritide 62 Nilotinib 62 cisplatin gemcitabine 62 Ophena TM 62 microtubule inhibitor 62 pregabalin Lyrica 62 Afatinib 62 HFA MDI 62 ADVANCE PD 62 omacetaxine mepesuccinate 62 OMP #M# 62 Fenofibrate 62 investigational monoclonal antibody 62 HCV protease inhibitors 62 GLPG# 62 monoclonal antibody MAb 62 INGN 62 Transdermal Patch 62 TYGACIL 62 rilonacept 62 candidate Zenvia 62 CB2 selective receptor agonist 62 TKB# 62 GVAX ® 62 Oral NKTR 62 INVIRASE 62 TRANSDUR ® 62 alkylating agent 62 RhuDex TM 62 REMINYL ® 62 Corgentin 62 SPIRIVA ® 62 alagebrium 62 investigational pharmacologically unique 62 Hectorol ® 62 Amrubicin 62 hoFH 62 Lixivaptan 62 MAA submission 62 Lenocta 62 specific lectin receptors 62 Frova ® 62 cetuximab Erbitux 62 Telmisartan 62 Auxilium Pharma 62 telomerase therapeutic 62 Well Tolerated 62 Oral Calcitonin 62 PENTASA 62 SomatoKine 62 CaPre TM 62 non porcine pancreatic 62 perampanel 62 DDP# 62 Marqibo TM 62 Chemophase 62 TH# [003] 62 A2 Lp PLA2 62 dasatinib Sprycel ® 62 TOCOSOL Camptothecin 62 Leukine 62 aurora kinase 62 thymalfasin 62 PROVENGE sipuleucel T 62 peptidic compound 62 Deferiprone 62 Levaquin levofloxacin 62 angiotensin receptor blocker ARB 62 cetuximab Erbitux R 62 pharmacokinetic PK study 62 CR# vcMMAE 62 trastuzumab DM1 62 Axid 62 diarrhea predominant irritable 62 LEUKINE 62 RSD# 62 Vernakalant 62 Captisol enabled 62 Phase 1b clinical trials 62 Plicera 62 Zybrestat 62 radiolabelled 62 Lopinavir 62 inhibit oxidative stress 62 Abstract Accepted 62 Rasagiline 62 Zemplar Capsules 62 DCCR 62 VivaGel ™ 62 icatibant 62 DermaVir Patch 62 PEG IFN 62 PEGylated interferon beta 1a 62 ACTEMRA TM 62 Fc fusion protein 62 Itraconazole 62 vivo validation 62 Mylan Receives Approval 62 Cancer Vaccines 62 Prostate Cancer Vaccine 62 Urocortin 2 62 Cytotoxicity 62 #D#C# 62 nalbuphine ER 62 Lupus Nephritis 62 Evista raloxifene 62 anticancer compound 62 sphingosine kinase 62 OXi# 62 CAMPATH 62 Zegerid OTC 62 inhaled formulation 62 LymphoStat B TM 62 Refractory Angina 62 BiovaxID TM 62 Vilazodone 62 reversible inhibitor 62 paclitaxel Taxol 62 TKM ApoB 62 Sporanox 62 Seliciclib 62 Argatroban 62 Nanoemulsion